Inactive Instrument

Insiders Correvio Pharma Corp Toronto S.E.

Equities

Mark Corrigan Departs as CEO from Correvio Pharma Corp	27/05/20	CI
Correvio Pharma Corp. Announces Management Changes	27/05/20	CI
Correvio Pharma Corp. Approves Appointment of W. James O'Shea as Director	19/06/19	CI
Correvio Pharma Corp. Announces Management Changes	13/03/19	CI
Correvio Pharma Corp Announces Executive Changes	02/01/19	CI
Cardiome Pharma Corp. Announces Management Changes	16/05/17	CI
Cardiome Pharma Corp. Announces Management Appointments	08/08/16	CI
Cardiome Pharma Corp. Announces Addition of Robert James Meyer to Board of Directors	08/09/15	CI
Cardiome Pharma Corp. Announces Executive Appointments	24/06/15	CI
Cardiome Pharma Corp. Appoints David Dean as Vice President, Business Development and Investor Relations	03/06/15	CI
Cardiome Pharma Announces Nomination of W. James O'Shea to Board of Directors	10/06/14	CI
Cardiome Pharma Appoints Jürgen Polifka, Ph.D., as General Manager, Sales and Marketing Europe	02/04/13	CI
Cardiome Pharma Corp. Adds Dr. Steen Juul-Möller as Medical Director, Europe	28/03/13	CI
Cardiome Pharma Corp. Announces Changes in Senior Management Team	26/03/13	CI
Cardiome Pharma Corp. Appoints Jennifer Archibald as Chief Financial Officer	20/09/12	CI
Cardiome Pharma Corp. Announces Management Change	03/07/12	CI

No results for this search